{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T11:46:15Z","timestamp":1759146375475,"version":"3.40.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,31]],"date-time":"2016-12-31T00:00:00Z","timestamp":1483142400000},"content-version":"vor","delay-in-days":1095,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurolog\u00eda"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.nrl.2013.01.008","type":"journal-article","created":{"date-parts":[[2013,4,16]],"date-time":"2013-04-16T20:07:58Z","timestamp":1366142878000},"page":"1-10","source":"Crossref","is-referenced-by-count":4,"title":["Manejo terap\u00e9utico con rivastigmina en pacientes con enfermedad de Alzheimer de leve a moderadamente grave en condiciones de pr\u00e1ctica cl\u00ednica habitual. Estudio ENTERPRISE"],"prefix":"10.1016","volume":"29","author":[{"given":"A.J.","family":"Cruz Jentoft","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrl.2013.01.008_bib0005","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1471-2377-10-87","article-title":"Behavioural symptoms in patients with Alzheimer's disease and their association with cognitive impairment","volume":"10","author":"Fernandez","year":"2010","journal-title":"BMC Neurol"},{"key":"10.1016\/j.nrl.2013.01.008_bib0010","unstructured":"Alzheimer's Disease International. World Alzheimer Report 2009. London; 2009."},{"key":"10.1016\/j.nrl.2013.01.008_bib0015","first-page":"859","article-title":"Rivastigmina: una revisi\u00f3n de su eficacia cl\u00ednica","volume":"35","author":"Spiegel","year":"2002","journal-title":"Rev Neurol"},{"key":"10.1016\/j.nrl.2013.01.008_bib0020","first-page":"CD001191","article-title":"Rivastigmine for Alzheimer's disease","author":"Birks","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nrl.2013.01.008_bib0025","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1185\/030079908X260961","article-title":"A systematic review of the effectiveness of rivastigmine for the treatment of behavioral disturbances in dementia and other neurological disorders","volume":"24","author":"Figiel","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.nrl.2013.01.008_bib0030","first-page":"275","article-title":"Utilizaci\u00f3n de f\u00e1rmacos espec\u00edficos para la enfermedad de Alzheimer","volume":"22","author":"Villar Fern\u00e1ndez","year":"2007","journal-title":"Neurolog\u00eda"},{"key":"10.1016\/j.nrl.2013.01.008_bib0035","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1742-1241.2009.02052.x","article-title":"Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer's disease: a review","volume":"63","author":"Kurz","year":"2009","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.nrl.2013.01.008_bib0040","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/sj.clpt.6100242","article-title":"Pharmacokinetics and pharmacodynamics of the novel daily rivastigmine transdermal patch compared with twice-daily capsules in Alzheimer's disease patients","volume":"83","author":"Lef\u00e8vre","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.nrl.2013.01.008_bib0045","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/gps.1788","article-title":"A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease\u2013rivastigmine patch versus capsule","volume":"22","author":"Winblad","year":"2007","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.nrl.2013.01.008_bib0050","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/WAD.0b013e31818b1c2c","article-title":"Safety and tolerability of the rivastigmine patch: results of a 28-week open-label extension","volume":"23","author":"Grossberg","year":"2009","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.nrl.2013.01.008_bib0055","unstructured":"Novartis Europharm Limited. Exel\u00f3n. Ficha t\u00e9cnica o resumen de las caracter\u00edsticas del producto. Disponible en: www.ema.europa.eu\/docs\/es_ES\/document_library\/EPAR_-_Product_Information\/human\/000169\/WC500032598.pdf"},{"key":"10.1016\/j.nrl.2013.01.008_bib0060","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2165\/00023210-200923040-00003","article-title":"Novel regimens and delivery systems in the pharmacological treatment of Alzheimer's disease","volume":"23","author":"Bassil","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.nrl.2013.01.008_bib0065","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2165\/00002512-200623050-00001","article-title":"Transdermal treatment options for neurological disorders: impact on the elderly","volume":"23","author":"Priano","year":"2006","journal-title":"Drugs Aging"},{"key":"10.1016\/j.nrl.2013.01.008_bib0070","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1185\/030079907X233403","article-title":"A review of compliance to treatment in Alzheimer's disease: potential benefits of a transdermal patch","volume":"23","author":"Small","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.nrl.2013.01.008_bib0075","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Text Revision: DSM-IV-TR. Washington, DC: American Psychiatric Association; 2000."},{"key":"10.1016\/j.nrl.2013.01.008_bib0080","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u00abMini-mental state\u00bb. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.nrl.2013.01.008_bib0085","doi-asserted-by":"crossref","first-page":"461","DOI":"10.33588\/rn.4608.2008131","article-title":"Patr\u00f3n de tratamiento de la enfermedad de Alzheimer con inhibidores colinester\u00e1sicos (estudio TRAIN)","volume":"46","author":"Gil-Neciga","year":"2008","journal-title":"Rev Neurol"},{"key":"10.1016\/j.nrl.2013.01.008_bib0090","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00005650-198601000-00007","article-title":"Concurrent and predictive validity of a self-reported measure of medication adherence","volume":"24","author":"Morisky","year":"1986","journal-title":"Med Care"},{"key":"10.1016\/j.nrl.2013.01.008_bib0095","doi-asserted-by":"crossref","first-page":"111","DOI":"10.31887\/DCNS.2009.11.2\/cqiu","article-title":"Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention","volume":"11","author":"Qiu","year":"2009","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.nrl.2013.01.008_bib0100","unstructured":"Alzheimer Europe. Who cares? The state of dementia care in Europe. Luxemburgo; 2006."},{"key":"10.1016\/j.nrl.2013.01.008_bib0105","unstructured":"Alzheimer Europe. Dementia in Europe Yearbook 2008. Luxemburgo; 2008."},{"key":"10.1016\/j.nrl.2013.01.008_bib0110","unstructured":"Alzheimer's Disease International. World Alzheimer Report 2010. The Global Economic Impact of Dementia. Londres; 2010."},{"key":"10.1016\/j.nrl.2013.01.008_bib0115","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1517\/14740330903439717","article-title":"Safety and tolerability of transdermal and oral rivastigmine in Alzheimer's disease and Parkinson's disease dementia","volume":"9","author":"Darreh-Shori","year":"2010","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.nrl.2013.01.008_bib0120","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1517\/17425240802542690","article-title":"Use of rivastigmine transdermal patch in the treatment of Alzheimer's disease","volume":"5","author":"Winblad","year":"2008","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.nrl.2013.01.008_bib0125","unstructured":"Cummings J, Fr\u00f6lich L, Black SE, Bakchine S, Bellelli G, Molinuevo JL, et al. A new option to reach maximum dose efficacy with rivastigmine patch in the treatment of Alzheimer's disease: results of a 48-week, randomized, double-blind evaluation of the comparative efficacy, safety and tolerability of 9.5mg\/24h and 13.3mg\/24h. 12th International Stockholm\/Springfield Symposium on Advances in Alzheimer Therapy. Abstract 28. 2012:137."},{"key":"10.1016\/j.nrl.2013.01.008_bib0130","doi-asserted-by":"crossref","first-page":"517","DOI":"10.33588\/rn.4609.2008183","article-title":"Estudio comparativo de la efectividad y tolerabilidad de un procedimiento de escalado lento de dosis de rivastigmina en pacientes con demencia tipo Alzheimer leve o moderada: estudio SCALEX","volume":"46","author":"Ag\u00fcera-Ortiz","year":"2008","journal-title":"Rev Neurol"},{"key":"10.1016\/j.nrl.2013.01.008_bib0135","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1185\/03007995.2010.493788","article-title":"Predictors of adherence among Alzheimer's disease patients receiving oral therapy","volume":"26","author":"Borah","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.nrl.2013.01.008_bib0140","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2165\/0002512-200825120-00005","article-title":"Adherence to medication in patients with dementia: predictors and strategies for improvement","volume":"25","author":"Arlt","year":"2008","journal-title":"Drugs Aging"},{"key":"10.1016\/j.nrl.2013.01.008_bib0145","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1586\/ern.11.178","article-title":"Impact of transdermal drug delivery on treatment adherence in patients with Alzheimer's disease","volume":"12","author":"Molinuevo","year":"2012","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.nrl.2013.01.008_bib0150","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/gps.1806","article-title":"Caregiver preference for rivastigmine patch relative to capsules for treatment of probable Alzheimer's disease","volume":"22","author":"Winblad","year":"2007","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.nrl.2013.01.008_bib0155","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s12325-009-0034-5","article-title":"Alzheimer's disease treatment: assessing caregiver preferences for mode of treatment delivery","volume":"26","author":"Abetz","year":"2009","journal-title":"Adv Ther"},{"key":"10.1016\/j.nrl.2013.01.008_bib0160","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.nrl.2010.10.007","article-title":"Evaluaci\u00f3n de la conveniencia del cambio de v\u00eda de administraci\u00f3n de rivastigmina en pacientes con enfermedad de Alzheimer","volume":"26","author":"Blesa Gonzalez","year":"2011","journal-title":"Neurolog\u00eda"}],"container-title":["Neurolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485313000145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485313000145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T04:58:01Z","timestamp":1745989081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213485313000145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0213485313000145"],"URL":"https:\/\/doi.org\/10.1016\/j.nrl.2013.01.008","relation":{},"ISSN":["0213-4853"],"issn-type":[{"type":"print","value":"0213-4853"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}